{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:00:51Z","timestamp":1790229651658,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10815-013-0149-0","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T19:33:13Z","timestamp":1387222393000},"page":"213-220","source":"Crossref","is-referenced-by-count":61,"title":["Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms"],"prefix":"10.1007","volume":"31","author":[{"given":"Sezai","family":"Sahmay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Oncul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent M.","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"149_CR1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544\u201351.","journal-title":"Hum Reprod"},{"key":"149_CR2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853\u201361.","journal-title":"N Engl J Med"},{"key":"149_CR3","first-page":"571","volume":"81","author":"MM Lee","year":"1996","unstructured":"Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. M\u00fcllerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81:571\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","volume":"77","author":"A Vet de","year":"2002","unstructured":"de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. AntiM\u00fcllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357\u201362.","journal-title":"Fertil Steril"},{"key":"149_CR5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2012.04451.x","volume":"77","author":"RA Anderson","year":"2012","unstructured":"Anderson RA. What does anti-M\u00fcllerian hormone tell you about ovarian function? Clin Endocrinol (Oxf). 2012;77:652\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"149_CR6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","volume":"20","author":"R Fanchin","year":"2005","unstructured":"Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-M\u00fcllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod. 2005;20:923\u20137.","journal-title":"Hum Reprod"},{"key":"149_CR7","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","volume":"91","author":"WJ Hehenkamp","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12522-010-0066-1","volume":"10","author":"S Sahmay","year":"2011","unstructured":"Sahmay S, Cetin M, Ocal P, Kaleli S, Senol H, Birol F, et al. Serum anti-M\u00fcllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients. Reprod Biol Endocrinol. 2011;10:9\u201314.","journal-title":"Reprod Biol Endocrinol"},{"key":"149_CR9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","volume":"28","author":"P Ocal","year":"2011","unstructured":"Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28:1197\u2013203.","journal-title":"J Assist Reprod Genet"},{"key":"149_CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10815-012-9754-6","volume":"29","author":"S Sahmay","year":"2012","unstructured":"Sahmay S, Demirayak G, Guralp O, Ocal P, Senturk LM, Oral E, et al. Serum anti-M\u00fcllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF\/ICSI cycles. J Assist Reprod Genet. 2012;29:589\u201395.","journal-title":"J Assist Reprod Genet"},{"key":"149_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2013.769519","volume":"29","author":"S Sahmay","year":"2013","unstructured":"Sahmay S, Guralp O, Aydogan B, Cepni I, Oral E, Irez T. Anti-M\u00fcllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients. Gynecol Endocrinol. 2013;29:440\u20133.","journal-title":"Gynecol Endocrinol"},{"key":"149_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","volume":"14","author":"S Franks","year":"2008","unstructured":"Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14:367\u201378.","journal-title":"Hum Reprod Update"},{"key":"149_CR13","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-M\u00fcllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88:5957\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77\u201383.","journal-title":"Mol Hum Reprod"},{"key":"149_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-M\u00fcllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10:107\u201317.","journal-title":"Hum Reprod Update"},{"key":"149_CR17","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab. 2010;95:4399\u2013405.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","volume":"98","author":"RL Rosenfield","year":"2012","unstructured":"Rosenfield RL, Wroblewski K, Padmanabhan V, Littlejohn E, Mortensen M, Ehrmann DA. AntiM\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012;98:242\u20139.","journal-title":"Fertil Steril"},{"key":"149_CR19","doi-asserted-by":"crossref","unstructured":"Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. M\u00fcllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol. 2007;196:77 e1\u20135.","DOI":"10.1016\/j.ajog.2006.07.046"},{"key":"149_CR20","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","volume":"23","author":"M Das","year":"2008","unstructured":"Das M, Gillott DJ, Saridogan E, Djahanbakhch O. Anti-M\u00fcllerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod. 2008;23:2122\u20136.","journal-title":"Hum Reprod"},{"key":"149_CR21","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR22","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","volume":"90","author":"RS Legro","year":"2005","unstructured":"Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab. 2005;90:2571\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR23","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"149_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u201388.","journal-title":"Fertil Steril"},{"key":"149_CR25","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377."},{"key":"149_CR26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","volume":"2","author":"J Adams","year":"1985","unstructured":"Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985;2:1375\u20139.","journal-title":"Lancet"},{"key":"149_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9:505\u201314.","journal-title":"Hum Reprod Update"},{"key":"149_CR28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","volume":"94","author":"FJ Broekmans","year":"2010","unstructured":"Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044\u201351.","journal-title":"Fertil Steril"},{"issue":"1","key":"149_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","volume":"170","author":"S Sahmay","year":"2013","unstructured":"Sahmay S, Atakul N, Ocul M, Tuten A, Aydogan B, Seyisoglu H. Serum anti-M\u00fcllerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):157\u201361.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"149_CR30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/09513590701485212","volume":"23","author":"S Weerakiet","year":"2007","unstructured":"Weerakiet S, Lertvikool S, Tingthanatikul Y, Wansumrith S, Leelaphiwat S, Jultanmas R. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling. Gynecol Endocrinol. 2007;23:455\u201360.","journal-title":"Gynecol Endocrinol"},{"key":"149_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","volume":"77","author":"CL Cook","year":"2002","unstructured":"Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum M\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002;77:141\u20136.","journal-title":"Fertil Steril"},{"key":"149_CR32","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","volume":"20","author":"T Piltonen","year":"2005","unstructured":"Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005;20:1820\u20136.","journal-title":"Hum Reprod"},{"key":"149_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12522-011-0078-5","volume":"10","author":"S Sahmay","year":"2011","unstructured":"Sahmay S, Guralp O, Senturk L, Imamoglu M, Kucuk M, Irez T. Serum anti-M\u00fcllerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index. Reprod Med Biol. 2011;10:113\u201320.","journal-title":"Reprod Med Biol"},{"key":"149_CR34","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/humrep\/dep101","volume":"24","author":"RL Thomson","year":"2009","unstructured":"Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, et al. The effect of weight loss on anti-M\u00fcllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Hum Reprod. 2009;24:1976\u201381.","journal-title":"Hum Reprod"},{"key":"149_CR35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/humrep\/deq380","volume":"26","author":"L Bungum","year":"2011","unstructured":"Bungum L, Jacobsson AK, Rosen F, Becker C, Yding Andersen C, Guner N, et al. Circadian variation in concentration of anti-M\u00fcllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum Reprod. 2011;26:678\u201384.","journal-title":"Hum Reprod"},{"key":"149_CR36","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","volume":"29","author":"Y Li","year":"2012","unstructured":"Li Y, Ma Y, Chen X, Wang W, Zhang Q, Yang D. Different diagnostic power of anti-M\u00fcllerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet. 2012;29:1147\u201351.","journal-title":"J Assist Reprod Genet"},{"key":"149_CR37","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, et al. Serum anti-M\u00fcllerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20:1814\u20139.","journal-title":"Hum Reprod"},{"key":"149_CR38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2004.05.098","volume":"83","author":"R Fleming","year":"2005","unstructured":"Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J, Sattar N, et al. Metformin reduces serum M\u00fcllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril. 2005;83:130\u20136.","journal-title":"Fertil Steril"},{"key":"149_CR39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","volume":"82","author":"A Marca La","year":"2004","unstructured":"La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. M\u00fcllerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82:970\u20132.","journal-title":"Fertil Steril"},{"key":"149_CR40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JS Laven","year":"2004","unstructured":"Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"149_CR41","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-M\u00fcllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296:E238\u201343.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"149_CR42","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","volume":"27","author":"TB Eilertsen","year":"2012","unstructured":"Eilertsen TB, Vanky E, Carlsen SM. Anti-M\u00fcllerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012;27:2494\u2013502.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-013-0149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-013-0149-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-013-0149-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T20:20:47Z","timestamp":1564950047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-013-0149-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s10815-013-0149-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}